Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yishen Wang
Institution:
Royal Free London NHS Foundation Trust
Observed institutions:
Barking, Havering And Redbridge University Hospitals NHS Trust,
Royal Free London NHS Foundation Trust,
Barts Health NHS Trust,
University of Cambridge
ORCID:
0000-0003-4575-962X
Observed ORCID:
0000-0003-4575-962X
OpenAlex ID:
A5005089816
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer
2022
·
Yishen Wang
, Joao R. Galante
, et al.
·
Nature Reviews Urology
·
59
PDF
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer
2025
·
Sola Adeleke
, Joao R. Galante
, et al.
·
Nature Reviews Urology
·
3
Endocrine monitoring when initiating immunotherapy in cancer patients: a quality improvement project
2025
·
Furhana Hussein
, Craig Hendry
, et al.
·
Endocrine Abstracts
Outcomes and safety of subsequent treatments after immune- and anti-VEGF therapy in patients with metastatic clear-cell renal cell carcinoma: Outcomes from a tertiary referral hospital.
2023
·
Jose Carlos Tapia
, Charlotte Toms
, et al.
·
Journal of Clinical Oncology
Immune-related adverse events after ≥12 months of starting immune checkpoint inhibitors.
2023
·
Agne Jovaisaite
, Marina Serrano
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
5
Citation count:
63
H-index:
2
I10-index:
1
Year
Topic
Type